文献速递类风湿关节炎其他结缔组织病

梅尼埃病中的自身免疫性关节炎:一项系统性文献综述

Autoimmune arthritis in Ménière's disease: A systematic review of the literature.
PubMed 文献 · Semin Arthritis Rheum · 2017-11-29

该系统综述按PRISMA指南检索MEDLINE、EMBASE及手动参考文献,最终纳入8项研究分析。梅尼埃病患者中自身免疫性关节炎患病率(1.0-10.0%)高于一般人群(0-1.1%),家族性梅尼埃病高于散发性(16.9% vs 4.5%,p=0.002)。最常见的自身免疫性关节炎为类风湿关节炎,平均点患病率4.3%。

要点

  • 梅尼埃病患者中自身免疫性关节炎患病率为1.0-10.0%,高于一般人群的0-1.1%。
  • 家族性梅尼埃病自身免疫性关节炎患病率16.9%高于散发性4.5%(p=0.002)。
  • 最常见自身免疫性关节炎为类风湿关节炎,平均点患病率4.3%。

核心结论

  • 因缺乏随机对照试验和原创前瞻性研究,证据水平低;但本综述识别出梅尼埃病中自身免疫性关节炎的最新点患病率数据,提示自身免疫性关节炎在梅尼埃病人群中更常见。
  • 作者认为,将梅尼埃病作为局部自身免疫病进行随机对照试验治疗将增进对该病的理解,并可能改变管理梅尼埃病的方式。

研究设计与样本

  • 该系统综述按PRISMA指南进行,检索MEDLINE、EMBASE及手动参考文献,时间范围为1947年至2017年5月。
  • 研究方案注册于PROSPERO数据库(试验注册号:CRD42017070516)。
  • 由两名独立审阅者筛选出237篇摘要,依据纳入和排除标准选出9项研究进行质量评估,最终8项研究纳入系统综述分析。
  • 因研究方法与测量指标异质性大,无法进行Meta分析,改为对文献结果进行定性综合。

主要发现

  • 梅尼埃病患者中自身免疫性关节炎患病率(1.0-10.0%)高于一般人群(0-1.1%)。
  • 家族性梅尼埃病患者自身免疫性关节炎患病率16.9% vs 散发性梅尼埃病患者4.5%(p=0.002)。
  • 无证据提示免疫学特征或所选治疗方案存在差异。
  • 梅尼埃病患者中最常报告的自身免疫性关节炎为类风湿关节炎,平均点患病率4.3%。
  • 许多研究未标准化其诊断标准,也未测量具有临床意义的结局。

关键数值与推荐

  • 梅尼埃病患者中自身免疫性关节炎患病率为1.0-10.0%,一般人群为0-1.1%。
  • 家族性梅尼埃病自身免疫性关节炎患病率16.9% vs 散发性梅尼埃病4.5%(p=0.002)。
  • 类风湿关节炎为梅尼埃病患者中最常报告的自身免疫性关节炎,平均点患病率4.3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 因缺乏随机对照试验和原创前瞻性研究,证据水平低。
  • 因研究方法与测量指标异质性大,无法进行Meta分析,改为定性综合。
  • 许多研究未标准化其诊断标准,也未测量具有临床意义的结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Successful management of patients with Ménière's disease (MD) involves understanding the pathophysiology of the disease and its comorbidities. The role of autoimmune diseases (AD) in MD remains unclear. The aim of this study was to further investigate the association between MD and AD. Specific goals were to characterize the prevalence, distribution, clinical and laboratory findings, and outcomes of autoimmune arthritis (AA) in MD. EVIDENCE REVIEW: This systematic review was conducted according to PRISMA guidelines. Articles were identified through searches of MEDLINE, and EMBASE, as well as manual reviews of references, from 1947 to May 2017. We performed a systematic review of randomized-controlled trials (RCTs) and non-RCTs of cases of AA in MD. Due to the heterogeneity of the study methods and measures, a meta-analysis was not possible and a qualitative synthesis of the literature results was performed. The study protocol was registered with PROSPERO database (Trial Registration: CRD42017070516). FINDINGS: A total of 237 abstracts were identified and screened by two independent reviewers. Based on inclusion and exclusion criteria, nine studies were selected and subjected to a quality assessment. This quality control measure yielded eight studies for analysis in the systematic review. The prevalence of AA was higher in MD (1.0-10.0%) as compared to the general population (0-1.1%), and noted to be higher in patients with familial MD as compared to sporadic MD (16.9% vs 4.5%, p = 0.002). There was no evidence to suggest a difference in immunologic profiles or selected treatment regimens. The most commonly reported AA in patients with MD was rheumatoid arthritis with a mean point prevalence of 4.3%. Many studies did not standardize their diagnostic criteria and did not measure clinically meaningful outcomes. CONCLUSIONS: There is a low level of evidence because of the lack of RCTs and original prospective studies. However, in this systematic review, we have identified the latest point prevalence data on AA in MD, indicating AA to be more prevalent within the MD population. RCTs treating MD as a local AD will enhance our understanding of the disease, and potentially change the way we manage MD.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Caulley L, Quimby A, Karsh J, et al. Autoimmune arthritis in Ménière's disease: A systematic review of the literature. Semin Arthritis Rheum. 2017. PMID: 29287768. doi:10.1016/j.semarthrit.2017.11.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。